TruBridge, Inc. (NASDAQ: TBRG)

Sector: Healthcare Industry: Health Information Services CIK: 0001169445
Market Cap 339.98 Mn
P/B 1.89
P/E 60.97
P/S 0.97
ROIC (Qtr) 30.17
Div Yield % 0.00
Rev 1y % (Qtr) 1.66
Total Debt (Qtr) 165.93 Mn
Debt/Equity (Qtr) 0.92

About

TruBridge, Inc. (TBRG), a prominent player in the healthcare industry, specializes in providing solutions and services to community hospitals. The company's offerings encompass revenue cycle management (RCM), electronic health record (EHR) products, and patient engagement technology, serving over 1,500 healthcare organizations. TruBridge's primary business activities revolve around healthcare IT, with a focus on catering to the unique needs of community hospitals. These activities span across three reportable segments: RCM, EHR, and Patient Engagement....

Read more

Price action

Investment thesis

Bull case

  • Healthy cash reserves of 19.92M provide 6.68x coverage of short-term debt 2.98M, demonstrating strong liquidity position and minimal refinancing risk.
  • Tangible assets of 115.05M provide exceptional 14.04x coverage of deferred revenue 8.20M, showing strong service capability backing.
  • Robust free cash flow of 23.67M exceeds capital expenditure of 14.73M by 1.61x, indicating strong organic growth funding capability.
  • Operating cash flow of 38.40M provides strong 4.69x coverage of deferred revenue 8.20M, indicating service delivery capability.
  • Operating cash flow of 38.40M provides strong 109.41x coverage of inventory 351000, indicating efficient inventory management.

Bear case

  • Operating cash flow of 38.40M barely covers its investment activities of (12.63M), with a coverage ratio of -3.04, indicating heavy reliance on external financing for growth which may not be sustainable in a tighter credit environment.
  • Investment activities of (12.63M) provide weak support for R&D spending of 32.36M, which is -0.39x, suggesting potentially insufficient investment in innovation relative to other capital deployment.
  • High receivables of 56.77M relative to inventory of 351000 (161.74 ratio) suggests aggressive credit terms or collection difficulties, potentially masking revenue quality issues.
  • Operating earnings of 23.78M show weak coverage of depreciation charges of 27.67M, with a 0.86 ratio indicating high capital intensity and potential reinvestment needs.
  • Free cash flow of 23.67M represents just -1.89x of debt issuance (12.50M), suggesting concerning reliance on leverage rather than internal cash generation for growth.

Segments Breakdown of Revenue (2024)

Segments Breakdown of Revenue (2024)

Peer comparison

Companies in the Health Information Services
S.No. Ticker Company Market Cap P/E P/S Total Debt (Qtr)
1 TEM Tempus AI, Inc. 45.63 Bn -223.83 41.29 1.34 Bn
2 GEHC GE HealthCare Technologies Inc. 38.75 Bn 19.85 2.19 10.28 Bn
3 VEEV Veeva Systems Inc 37.30 Bn 43.36 12.11 0.09 Bn
4 DOCS Doximity, Inc. 7.81 Bn 30.87 12.57 0.01 Bn
5 BTSG BrightSpring Health Services, Inc. 7.70 Bn 59.42 0.62 2.70 Bn
6 HQY Healthequity, Inc. 7.32 Bn 38.14 5.67 1.03 Bn
7 WAY Waystar Holding Corp. 5.00 Bn 44.97 4.81 1.25 Bn
8 PRVA Privia Health Group, Inc. 2.79 Bn 153.67 1.37 0.01 Bn

Industry comparisons

Current Valuation Value Ind Avg Percentile
EV to Assets EV to Assets 1.24 2.77
EV to Cash from Ops. EV/CFO 12.91 -10.86
EV to Debt EV to Debt 2.99 161.93
EV to EBIT EV/EBIT 20.84 -106.48
EV to EBITDA EV/EBITDA 9.41 4.22
EV to Free Cash Flow [EV/FCF] EV/FCF 20.94 7.46
EV to Market Cap EV to Market Cap 1.46 -14.93
EV to Revenue EV/Rev 1.42 1.76
Price to Book Value [P/B] P/B 1.89 10.57
Price to Earnings [P/E] P/E 60.97 147.14
Dividend Metrics Value Ind Avg Percentile
Dividend Coverage Ratio Div Coverage (Qtr) 0.00 -8.65
Dividend Payout Ratio % Div Payout % (Qtr) 0.00 5.00
Dividend per Basic Share Div per Share (Qtr) 0.00 0.04
FCF Dividend Payout Ratio % FCF Div Payout % (Qtr) 0.00 4.57
Interest Coverage Int. cover (Qtr) 1.79 -584.72
Growth Metrics Value Ind Avg Percentile
Capex Growth (1y) % Capex 1y % (Qtr) 26.48 -24.09
Cash and Equivalents Growth (1y) % Cash & Equiv 1y % (Qtr) 132.01 172.48
Dividend Growth (1y) % Div 1y % (Qtr) 0.00 -1.05
EBIAT Growth (1y) % EBIAT 1y % (Qtr) 128.67 -17.73
EBITDA Growth (1y) % EBITDA 1y % (Qtr) 492.73 39.85
EBIT Growth (1y) % EBIT 1y % (Qtr) 154.21 -38.83
EBT Growth (1y) % EBT 1y % (Qtr) 117.42 -4.52
EPS Growth (1y) % EPS 1y % (Qtr) 108.70 2.60
FCF Growth (1y) % FCF 1y % (Qtr) 326.41 -48.57
Gross Profit Growth (1y) % Gross Profit 1y % (Qtr) 12.29 5.49
Liquidity Ratios Value Ind Avg Percentile
Asset Utilization Ratio Asset Util Ratio (Qtr) 0.88 0.66
Cash Payout Ratio Cash Payout (Qtr) 0.00 0.03
Cash Ratio Cash Ratio (Qtr) 0.37 1.87
Current Ratio Curr Ratio (Qtr) 1.91 3.27
Debt to Equity Ratio Debt/Equity (Qtr) 0.92 -0.43
Interest Cover Ratio Int Coverage (Qtr) 1.79 -584.72
Times Interest Earned Times Interest Earned (Qtr) 1.79 -584.72
Profitability Value Ind Avg Percentile
EBITDA Margin % EBITDA Margin % (Qtr) 14.70 -435.80
EBIT Margin % EBIT Margin % (Qtr) 6.80 -464.70
EBT Margin % EBT Margin % (Qtr) 3.00 -461.74
Gross Margin % Gross Margin % (Qtr) 53.20 44.03
Net Profit Margin % Net Margin % (Qtr) 1.60 -468.01